The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 28, 2021

Filed:

Sep. 20, 2019
Applicant:

Levo Therapeutics, Inc., Skokie, IL (US);

Inventors:

Christopher Bryant, Burr Ridge, IL (US);

Mark C. Manning, Johnstown, CO (US);

Ryan E. Holcomb, Fort Collins, CO (US);

Assignee:

LEVO THERAPEUTICS, INC., Skokie, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2006.01); A61K 38/095 (2019.01); A61K 47/38 (2006.01); A61K 47/26 (2006.01); A61K 47/22 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 38/095 (2019.01); A61K 9/08 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01);
Abstract

The present disclosure includes a method of making an improved carbetocin drug product. The disclosed method for making an improved carbetocin drug product comprises agitating a carbetocin preparation containing an aqueous solution of carbetocin and one or more excipients for a period of time to initiate the formation of aggregate-forming solids and filtering off the aggregates that form before further processing the remaining carbetocin into a final drug product. The present disclosure also relates to an improved carbetocin drug product, wherein the drug product is substantially free of aggregate-forming solids. The disclosed carbetocin drug product can be used for the treatment of a neurodevelopmental disorder, such as Präder-Willi syndrome. Additionally, the disclosed carbetocin drug product shows content uniformity of carbetocin over long periods of time before and after one or more freeze/thaw cycles, provides enhanced convenience and patient compliance, and/or are highly concentrated.


Find Patent Forward Citations

Loading…